Table III.
Associations between baseline ctDNA concentrations and response to targeted treatment.
BRAFV600E mutation | PR | SD | PD | Total | P-value |
---|---|---|---|---|---|
UT | 3 | 6 | 0 | 9 | 0.30 |
MT | 10 | 7 | 1 | 18 | |
Total | 13 | 13 | 1 | 27 |
Qualitative data were statistically analyzed using Mann-Whitney U tests. UT, undetectable type; MT, mutant type; PR, partial responses; SD, stable disease; PD, progressive disease.